Brian Dalby

Summary

Affiliation: Invitrogen Corporation
Country: USA

Publications

  1. ncbi Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications
    Brian Dalby
    Invitrogen Corporation Research and Development, 1610 Faraday Avenue, Carlsbad, CA 92008, USA
    Methods 33:95-103. 2004
  2. ncbi Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells
    Chaoting Liu
    Research and Development, Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, CA 92008, USA
    Mol Biotechnol 39:141-53. 2008
  3. ncbi Protein delivery using VP22
    Robert P Bennett
    Nat Biotechnol 20:20. 2002

Collaborators

Detail Information

Publications3

  1. ncbi Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications
    Brian Dalby
    Invitrogen Corporation Research and Development, 1610 Faraday Avenue, Carlsbad, CA 92008, USA
    Methods 33:95-103. 2004
    ....
  2. ncbi Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells
    Chaoting Liu
    Research and Development, Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, CA 92008, USA
    Mol Biotechnol 39:141-53. 2008
    ..Our results showed that the higher quantity of protein production was obtained by using optimal transient transfection conditions in serum-free adapted suspension mammalian cells...
  3. ncbi Protein delivery using VP22
    Robert P Bennett
    Nat Biotechnol 20:20. 2002